118 related articles for article (PubMed ID: 34976850)
1. A New Biomarker of Fecal Bacteria for Non-Invasive Diagnosis of Colorectal Cancer.
Yao Y; Ni H; Wang X; Xu Q; Zhang J; Jiang L; Wang B; Song S; Zhu X
Front Cell Infect Microbiol; 2021; 11():744049. PubMed ID: 34976850
[TBL] [Abstract][Full Text] [Related]
2. Development of fecal microbial diagnostic marker sets of colorectal cancer using natural language processing method.
Liu H; Song C; Wang J; Chen Z; Zhang X; Zhou H; Yao L; Chen D; Gu W; Huang RK; Huang BK; Han BW; Du J
Int J Biol Markers; 2024 Mar; 39(1):31-39. PubMed ID: 38128926
[TBL] [Abstract][Full Text] [Related]
3. Risk-Predictive and Diagnostic Biomarkers for Colorectal Cancer; a Systematic Review of Studies Using Pre-Diagnostic Blood Samples Collected in Prospective Cohorts and Screening Settings.
Harlid S; Gunter MJ; Van Guelpen B
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503217
[TBL] [Abstract][Full Text] [Related]
4. Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review.
Han S; Gao J; Zhou Q; Liu S; Wen C; Yang X
Cancer Manag Res; 2018; 10():199-206. PubMed ID: 29440929
[TBL] [Abstract][Full Text] [Related]
5. Application and development of noninvasive biomarkers for colorectal cancer screening.
Yang Y; Wang J; Lin J; Wu C
Int J Surg; 2024 Feb; 110(2):1325-1326. PubMed ID: 38016141
[No Abstract] [Full Text] [Related]
6. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota in colorectal cancer development and therapy.
Wong CC; Yu J
Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites.
Bai X; Wei H; Liu W; Coker OO; Gou H; Liu C; Zhao L; Li C; Zhou Y; Wang G; Kang W; Ng EK; Yu J
Gut; 2022 Dec; 71(12):2439-2450. PubMed ID: 35387878
[TBL] [Abstract][Full Text] [Related]
9. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of fecal viromes demonstrates high diagnostic potential of the gut viral signatures for colorectal cancer and adenoma risk assessment.
Chen F; Li S; Guo R; Song F; Zhang Y; Wang X; Huo X; Lv Q; Ullah H; Wang G; Ma Y; Yan Q; Ma X
J Adv Res; 2023 Jul; 49():103-114. PubMed ID: 36198381
[TBL] [Abstract][Full Text] [Related]
11. Mutualistic interplay between bacteriophages and bacteria in the human gut.
Shkoporov AN; Turkington CJ; Hill C
Nat Rev Microbiol; 2022 Dec; 20(12):737-749. PubMed ID: 35773472
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.
Du X; Li Q; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Chen G; Yue H; Li J; Zhao M; Han YP; Fu X
Front Physiol; 2022; 13():854545. PubMed ID: 35600308
[No Abstract] [Full Text] [Related]
13. Alterations of Gut Mycobiota Profiles in Adenoma and Colorectal Cancer.
Gao R; Xia K; Wu M; Zhong H; Sun J; Zhu Y; Huang L; Wu X; Yin L; Yang R; Chen C; Qin H
Front Cell Infect Microbiol; 2022; 12():839435. PubMed ID: 35281451
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer and gut microbiota studies in China.
Wang Z; Dan W; Zhang N; Fang J; Yang Y
Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
[TBL] [Abstract][Full Text] [Related]
15. A small molecule inhibitor prevents gut bacterial genotoxin production.
Volpe MR; Velilla JA; Daniel-Ivad M; Yao JJ; Stornetta A; Villalta PW; Huang HC; Bachovchin DA; Balbo S; Gaudet R; Balskus EP
Nat Chem Biol; 2023 Feb; 19(2):159-167. PubMed ID: 36253549
[TBL] [Abstract][Full Text] [Related]
16. Methanogenic archaea in the human gastrointestinal tract.
Hoegenauer C; Hammer HF; Mahnert A; Moissl-Eichinger C
Nat Rev Gastroenterol Hepatol; 2022 Dec; 19(12):805-813. PubMed ID: 36050385
[TBL] [Abstract][Full Text] [Related]
17. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota Enterotypes Mediate the Effects of Dietary Patterns on Colorectal Neoplasm Risk in a Chinese Population.
Cai JA; Zhang YZ; Yu ED; Ding WQ; Jiang QW; Cai QC; Zhong L
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447266
[TBL] [Abstract][Full Text] [Related]
19. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
20. Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors.
Shaikh FY; Gills JJ; Mohammad F; White JR; Stevens CM; Ding H; Fu J; Tam A; Blosser RL; Domingue JC; Larman TC; Chaft JE; Spicer JD; Reuss JE; Naidoo J; Forde PM; Ganguly S; Housseau F; Pardoll DM; Sears CL
Cancer Immunol Immunother; 2022 Oct; 71(10):2405-2420. PubMed ID: 35217892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
